FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

377570002: Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2638995018 Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2642975017 Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution Is a Product containing sulfacetamide (medicinal product) false Inferred relationship Some
    Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution Is a Product containing prednisolone (medicinal product) false Inferred relationship Some
    Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution Is a Product containing prednisolone in ocular dose form (medicinal product form) false Inferred relationship Some
    Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Sulfacetamide (substance) false Inferred relationship Some
    Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Prednisolone ophthalmic preparation false Inferred relationship Some
    Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Prednisolone sodium phosphate false Inferred relationship Some
    Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Corticosterone false Inferred relationship Some
    Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Sulfacetamide sodium false Inferred relationship Some
    Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Adrenal hormone agent false Inferred relationship Some
    Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution Is a Product containing prednisolone sodium phosphate false Inferred relationship Some
    Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Glucocorticoid hormone false Inferred relationship Some
    Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bactericide false Inferred relationship Some
    Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution Is a Prednisolone acetate + sulfacetamide sodium false Inferred relationship Some
    Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Prednisolone acetate false Inferred relationship Some
    Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution Has manufactured dose form Ocular dose form (dose form) false Inferred relationship Some
    Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution Is a Product containing sulfacetamide in ophthalmic dosage form false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Description inactivation indicator reference set

    GB English

    US English

    Back to Start